In order to examine the biological activity for sPD-L1 in vivo, we used a murine tumour model, based on transplantation of MCA-38 colon adenocarcinoma cells, which is responsive to PD-1 or PD-L1 blockade (Gong et al., 2019). This evidence concerns the gene PDCD1 and neoplasm.